Concepedia

Early Detection of Recurrent Ovarian Cancer in Patients with Low-Level Increases in Serum CA-125 Levels by 2-[F-18]Fluoro-2-Deoxy- <scp>d</scp> -Glucose-Positron Emission Tomography/Computed Tomography

Nan-Jing Peng, Wen-Shiung Liou, Chin Hu, Daw-Guey Tsay, Cheng-Bin Liu

Cancer Biotherapy and Radiopharmaceuticals · 2011 · 31 citations · 20 references

DOI

Abstract

FDG-PET/CT has the ability to detect recurrent ovarian cancer and second primary tumors in patients with increased levels of serum CA-125. FDG-PET/CT affects the clinical management by localizing recurrent lesions and creating a specific treatment plan for each patient, especially patients who demonstrate a low-level increase in serum CA-125 levels.

References

20

Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry

Bruce E. Hillner, Barry A. Siegel, Dawei Liu et al. · Journal of Clinical Oncology · 2008 · 373 citations

Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study

G.J.S. Rustin, Ann E. Nelstrop, Malgorzata Tuxen et al. · Annals of Oncology · 1996 · 284 citations · Full text

, , +8

Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels

Gordon Rustin, Marples Maria, Ann E. Nelstrop et al. · Journal of Clinical Oncology · 2001 · 202 citations

Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry

Bruce E. Hillner, Barry A. Siegel, Anthony F. Shields et al. · Journal of Nuclear Medicine · 2008 · 196 citations · Full text

Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT

Robert E. Bristow, Marcela G. del Carmen, Harpreet K. Pannu et al. · Gynecologic Oncology · 2003 · 194 citations

, , +11